Substance Abuse & Addiction
Search All News
A Columbia study finds that adolescents who use cannabis recreationally are two to four times as likely to develop psychiatric disorders then teens who don’t use cannabis at all.
This new series highlights some of the up-and-coming faculty committed to our trifold mission of patient care, medical education, and scientific research.
This year’s Eric D. Hadar Distinguished Lecturer, Dr. Rajita Sinha, will present “Can We Rescue Stress and Trauma Related Pathophysiology in Addiction to Improve Treatment Outcomes?” on Nov. 16, 2022.
Patients who participate in fewer than two visits early in treatment are at risk for relapse, overdose, and possible death.
- September 15, 2022
Columbia psychiatrist Nasir Naqvi, MD, PhD, discusses which treatments for alcohol use disorder are most effective and the importance of community and support in treating AUD.
- June 22, 2022
Her influential ‘gateway hypothesis’ changed the way we think about addiction.
Source:The New York TimesMay 19, 2022
Jermaine Jones, PhD, a neuroscientist at Columbia, teaches people to rouse individuals experiencing a fentanyl overdose by giving them a firm rub with their knuckles in the center of the chest.
Source:Associated PressApril 12, 2022
Katherine Keyes, director of Columbia’s Psychiatric Epidemiology Training Program, testified at an ongoing trial against three major pharmaceutical companies regarding the opioid epidemic.
Source:Big BrainsMarch 17, 2022
An opioid addiction vaccine is currently in the first phase of clinical trials, being led by Columbia Psychiatry's Sandra Comer, who directs the university’s Opioid Laboratory.
- January 26, 2022
Psychiatrist Carl Fisher discusses his book, The Urge: Our History of Addiction, which interweaves socio-cultural narratives with his experience as a clinician, researcher, and alcoholic in recovery.
- November 3, 2021
As more states legalize cannabis for medical or recreational purposes its use during pregnancy is increasing, along with the potential for abuse or dependence.
- October 27, 2021
This year’s Eric D. Hadar Lecture will take place on November 3, 2021 with Dr. Steven Shoptaw, who will present, “Medications as Foundation for Stimulant Use Disorder Treatment: Is it Time?”
- September 21, 2021
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
Source:NBC NewsJuly 16, 2021
“Our study provides further evidence that marijuana use is not effective in reducing nonmedical opioid use,” said study author Dr. Mark Olfson.